|
|
Article: SHIRE PLC - New Shire Board member.
- Article from:
- PR Newswire UK Disclose
- Article date:
- November 2, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
New Shire Board member
Dublin, Ireland - November 2, 2009 - The Board of Directors of Shire plc (LSE:
SHP, NASDAQ: SHPGY) announces that Mr David Stout joined the Board as a Non
Executive Director with effect from 31 October 2009.
Mr Stout has extensive pharmaceutical experience. Most recently he was
President, Pharmaceutical Operations at GSK. In this position he had
responsibility for pharmaceutical operations in the United States, Europe,
Japan and all other International Markets. Mr Stout was also responsible for
global manufacturing and global Biologics (vaccines) at GSK. Prior to that he
was President of GSK's US Pharmaceuticals Business and before that ...
Related newspaper, magazine, and journal articles:
|
|
Article: Shire Board Appoints New Chief Executive.
PR Newswire;
March 12, 2003 ;
700+ words
...The board of directors of Shire Pharmaceuticals Group plc announces that Matthew Emmens has been appointed today to the board and as chief executive of Shire. Matthew Emmens, 51, was most recently president of Merck KGaA's global prescription pharmaceuticals business which had sales of US$2 billion
|
|